Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM86HP (family with sequence similarity 86 member H, pseudogene) is classified as a pseudogene, meaning it is a DNA sequence similar to a functional gene but is typically noncoding and lacks a functional protein product. Pseudogenes like FAM86HP are generally regarded as non-functional remnants of gene duplication or retrotransposition events, though in rare cases some pseudogenes can be transcribed and exert indirect regulatory effects on related genes at the RNA level (e.g., through competitive endogenous RNA mechanisms or RNA interference). However, for FAM86HP, there is no strong evidence supporting such functions. It is not a therapeutic target or clinically actionable biomolecule and does not encode any receptor, enzyme, transporter, or known regulatory factor
None (there are no drugs targeting this gene, so no mechanism of action is described)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 86 member H, pseudogene (FAM86HP).